Novartis Units Pay $346M Over US Bribery Claims
Current and former subsidiaries of pharmaceutical giant Novartis AG have agreed to pay $345.9 million in penalties and profits over an alleged bribery scheme at hospitals in Greece and improper record-keeping...To view the full article, register now.
Already a subscriber? Click here to view full article